Equities

HOOKIPA Pharma Inc

HOOK:NAQ

HOOKIPA Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)4.72
  • Today's Change0.10 / 2.16%
  • Shares traded45.61k
  • 1 Year change-23.31%
  • Beta0.8392
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments11711266
Total Receivables, Net192221
Total Inventory------
Prepaid expenses111214
Other current assets, total00.540.57
Total current assets147147102
Property, plant & equipment, net132222
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.580.861.37
Total assets161170126
LIABILITIES
Accounts payable125.498.76
Accrued expenses13129.60
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.121.592.81
Other current liabilities, total15166.48
Total current liabilities423628
Total long term debt00.912.22
Total debt1.122.515.03
Deferred income tax------
Minority interest------
Other liabilities, total29316.58
Total liabilities716836
SHAREHOLDERS EQUITY
Common stock0.010.010.00
Additional paid-in capital467397317
Retained earnings (accumulated deficit)(369)(288)(223)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(7.93)(7.16)(4.78)
Total equity9010390
Total liabilities & shareholders' equity161170126
Total common shares outstanding127.636.56
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.